HPV疫苗接种对高级别宫颈病变发病率的群体效应:瑞典基于人群的队列研究
BACKGROUND: Human papillomavirus (HPV) vaccination has substantially reduced the incidence of high-grade cervical lesions (HSIL+) among vaccinated individuals. However, indirect effects on unvaccinated populations remain unclear.…
要点
- 学校-based HPV疫苗接种队列未接种女性HSIL+发病率显著低于机会性接种队列。
- 较高年龄组IRR随年龄增长而降低,提示群体效应随时间显现。
核心结论
- 学校-based HPV疫苗接种高覆盖率可产生群体效应,降低未接种女性的HSIL+发病率。
临床怎么用
- 支持通过学校-based高覆盖率HPV疫苗接种策略实现群体免疫,降低未接种女性宫颈高级别病变负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human papillomavirus (HPV) vaccination has substantially reduced the incidence of high-grade cervical lesions (HSIL+) among vaccinated individuals. However, indirect effects on unvaccinated populations remain unclear. We assessed herd effects by examining age-varying HSIL+ incidence among unvaccinated women in Sweden. METHODS: We conducted a nationwide, retrospective, register-based cohort study including 857 168 girls and women born between 1985 and 2000, using data from the Swedish National Cervical Screening Registry and several national health and population registries. Participants were grouped by birth cohorts exposed to different HPV vaccination strategies: opportunistic vaccination (1985-88; reference group), subsidised vaccination (1989-92), catch-up vaccination (1993-98), and school-based vaccination (1999-2000). Participants were followed up from age 10 years or from Jan 1, 2006, whichever came later, until their first HPV dose, an HSIL+ diagnosis, emigration, death, their 35th birthday, or Dec 31, 2022. Poisson regression was used to estimate age-constant and age-varying incidence rate ratios (IRRs) of HSIL+ among unvaccinated individuals across cohorts. FINDINGS: The study population, followed up from Jan 1, 2006, to Dec 31, 2022, consisted of 857 168 girls and women who had not been previously vaccinated for HPV or received a diagnosis of HSIL+ at baseline. We identified 42 274 cases of HSIL+, with cumulative incidence differing across birth cohorts and lowest in the 1999-2000 cohort. For participants aged 23 years, with the 1985-88 cohort as the reference group, the IRR of HSIL+ was 0·53 (95% CI 0·39-0·73) in the 1999-2000 cohort, 1·26 (1·19-1·34) in the 1993-98 cohort, and 1·26 (1·18-1·34) in the 1989-92 cohort. IRRs in the older cohorts were reduced with increased age, declining to 1·00 (0·87-1·05) by the age of 29 years for the 1993-98 cohort and 0·89 (0·80-0·99) by the age of 33 years for the 1989-92 cohort. INTERPRETATION: HSIL+ incidence in unvaccinated women declined in the birth cohort eligible for HPV vaccination through a school-based programme. This finding shows that the herd effect can be achieved through high-coverage HPV vaccination. FUNDING: Swedish Research Council, Swedish Research Council for Health, Working Life and Welfare, Karolinska Institutet, and Horizon Europe.
引用
- Meglic E, Ploner A, Clements M, et al. Herd effect of human papillomavirus vaccination on incidence of high-grade cervical lesions: a population-based cohort study in Sweden. Lancet Public Health. 2026. PMID: 41500739. doi:10.1016/S2468-2667(25)00297-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。